Kulicke and Soffa Industries, Inc. (KLIC): The share price got a big bump today....

Trueheart · 2017-11-15T05:12:54.7870000Z

The share price got a big bump today. Trueheart

Play Episode

11min

Proactive - Interviews for investors

West Cobar Metals' high-grade copper discovery: Bulla Park delivers exceptional results

West Cobar Metals Ltd (ASX:WC1) managing director Matt Szwedzicki talked with Proactive's Jonathan Jackson about the company’s latest metallurgical results from the Bulla Park project. Early-stage testing has delivered high-grade copper, silver, and antimony concentrates with strong recoveries. Szwedzicki described the initial float test results as amazing. A key challenge at Bulla Park has been the presence of tetrahedrite, a less common mineral in Australia. However, recent testing has demonstrated successful separation and recovery processes. The company has now achieved 88% extraction of antimony, a commodity that has surged in value due to reduced exports from China. Szwedzicki also discussed West Cobar’s broader strategy, including plans to optimise metallurgical processes, assess a mineral resource estimate, and advance drilling at Bulla Park. Beyond this, the company is progressing its Salazar project in Western Australia, which holds rare earths, scandium, and alumina resources. The recent acquisition of the Mystique Gold Project further strengthens West Cobar’s portfolio, adding a promising gold exploration target. Stay tuned for more updates from West Cobar Metals. If you enjoyed this interview, give the video a like, subscribe to Proactive’s YouTube channel, and turn on notifications for the latest mining insights. #WestCobarMetals #Copper #Antimony #Mining #ASX #BullaPark #RareEarths #GoldExploration #Metals #Investing #Resources

Proactive - Interviews for investors

KEFI Gold and Copper gets green light to progress with Tulu Kapi project in Ethiopia

KEFI Gold and Copper PLC executive chairman Harry Anagnostaras-Adams talked with Proactive about a major milestone for the company’s flagship Tulu Kapi gold project in Ethiopia. He described the latest announcement as the most significant since KEFI decided to focus on the Arabian Nubian Shield in 2008. Anagnostaras-Adams confirmed that all stakeholders in the project have now given the green light, marking the start of the next phase. He emphasised that there is no risk of being blocked, as land resettlement is progressing with the support of the local community. The process, involving thousands of people, is expected to be completed within a month, alongside final project preparations. He reiterated that the company has passed the “point of no return” and is now expediting the project’s launch. Investors seeking more details on KEFI’s technical, environmental, and financial studies can find extensive information on the company’s website: https://www.kefi-goldandcopper.com For more updates on KEFI Gold and Copper and other industry developments, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for the latest insights. Relevant Hashtags #KEFIGold #GoldMining #CopperMining #TuluKapi #EthiopiaMining #MiningInvestment #GoldStocks #ResourceSector #MiningUpdates #ProactiveInvestors

Proactive - Interviews for investors

Synchronoss unveils Capsyl Cloud at Mobile World Congress, partnering with Telkomsel for rollout

Synchronoss Technologies is expanding its cloud offerings with the launch of Capsyl Cloud, a next-generation personal cloud platform designed to help mobile operators and broadband providers quickly deploy secure, scalable, and revenue-generating cloud services. CEO Jeff Miller spoke with Steve Darling from Proactive and the company introduced the new platform at Mobile World Congress in Spain, The company highlighted its potential to transform how users store, manage, and protect their digital content. Capsyl Cloud is a turnkey, cross-platform solution that enables seamless access to photos, videos, documents, audio, contacts, and messages across smartphones, tablets, laptops, and desktops. Unlike traditional storage solutions, Capsyl Cloud leverages AI-powered tools to enhance how users organize, search, and optimize their digital memories. Features include AI-driven photo search capabilities, offering a more intuitive and personalized cloud experience. Developed through extensive beta testing since 2022, Capsyl Cloud is now entering the market with its first major deployment by Telkomsel, Indonesia’s largest mobile network operator. This partnership makes Capsyl Cloud available to millions of Telkomsel’s prepaid and postpaid subscribers, marking a significant milestone in Synchronoss’s strategy to bring innovative cloud solutions to global telecom providers. With Capsyl Cloud, Synchronoss continues to push the boundaries of AI-enhanced cloud technology, providing both users and service providers with a secure, intuitive, and future-ready digital storage solution. #proactiveinvestors #synchronosstechnologiesinc #nasdaq #sncr @cloud #CapsylCloud #AI #MobileWorldCongress #CloudTechnology #MachineLearning #TechInnovation #Telecom #DigitalTransformation #MWC2025

Proactive - Interviews for investors

Lisata Therapeutics expands drug discovery with GATC AI collaboration

Lisata Therapeutics Inc (NASDAQ:LSTA) CEO David Mazzo talked with Proactive about the company’s strategic collaboration with GATC Health, a leader in artificial intelligence-driven drug discovery. Mazzo explained that GATC’s technology, which is recognized by Lloyd’s of London for clinical trial risk assessment, will be used to analyze Lisata’s lead candidate, certepetide, and identify potential new drug combinations. Mazzo highlighted that this collaboration will optimize Lisata’s ongoing cancer research, including trials in pancreatic ductal adenocarcinoma, cholangiocarcinoma, and other cancers. He noted that GATC’s AI technology can perform billions of simulations rapidly, potentially reducing the cost and risk of drug development. Discussing Lisata’s 2025 outlook, Mazzo described it as a "data-rich year," with upcoming results from the ASCEND trial and other studies. He emphasized the potential for certepetide in combination with immunotherapy and the company’s ongoing discussions with regulatory agencies and potential partners. To watch more interviews like this, visit Proactive’s YouTube channel. Don't forget to like this video, subscribe, and enable notifications for future updates. #LisataTherapeutics #Biotech #CancerResearch #AIinHealthcare #DrugDevelopment #ClinicalTrials #GATCHealth #Pharma #Oncology #Investing

Followers	88
Posts	20652
Boards Moderated	0
Alias Born	06/16/2006

Volume:	486,707
Day Range:	36.05 - 36.96
Bid:	36.33
Ask:	39.90
Last Trade Time:	4:34:09 PM EDT
Total Trades:	8,611

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

KLIC Detailed Quote

Recent KLIC News

More KLIC News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent KLIC News

Go Ad-Free